Loading...
9 Middle East and Africa Cardiovascular Drugs Reports
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc, Novartis AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Baxter
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, F. Hoffmann La Roche Ltd., Johnson & Johnson, Pfizer Inc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline Plc., Bayer AG
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca Plc, Bayer AG, Sanofi S.A., Merck & Co., Inc, Novartis AG
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AstraZeneca Plc, Novartis AG, Pfizer Inc, Bayer AG, Kowa Pharmaceuticals America, Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Koninklijke Philips N.V, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Novartis AG
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Medtronic plc, LimFlow SA, Cardiovascular Systems, Inc, Eli Lilly and Company, Abbott Laboratories
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Mylan N.V., Teva Pharmaceutical Industries Ltd, Pfizer Inc, Sanofi, Upsher-Smith Laboratories, LLC
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Zensun Shanghai Sci & Tech Co Ltd, Capricor Therapeutics, Inc., Vericel Corporation, AstraZeneca plc., Pfizer Inc.
Filter Reports
By Countries
